Skip to main content
SpringerLink
Log in

Endometrial Cancers in Young Women: Conservative Management and Fertility Preserving Options

  • Chapter
Book cover Uterine Cancer

  • 1174 Accesses

Abstract

Endometrial cancer is increasingly being diagnosed in women <40 years. Around 1.6 % cases occur between 20 and 34 year age and 6 % between 35 and 44 years of age according to the SEER statistics [1]. A woman under the age of 40 has a 1 in 1423 risk of developing endometrial cancer [2]. Genetic predisposition and conditions with estrogen excess are the main risk factors. Women <40 years, with well differentiated stage 1a cancer can be offered conservative management after appropriate counseling and investigative work-up. Progestins form the mainstay of treatment in addition to other novel strategies. Pregnancy rates of 30-40% have been reported after conservative management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Howlader N et al. SEER cancer statistics review, 1975–2008. 2011 [cited 2011; based on Nov 2010 SEER data submission]. Available from: http://seer.cancer.gov/csr/1975_2008/

  2. Siegel R, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212–36.

    Article  PubMed  Google Scholar 

  3. Liu FS. Molecular carcinogenesis of endometrial cancer. Taiwan J Obstet Gynecol. 2007;46:26–32.

    Article  CAS  PubMed  Google Scholar 

  4. Smith RA, von Eschenbach AC, Wender R et al; ACS Prostate Cancer Advisory Committee, ACS Colorectal Cancer Advisory Committee, ACS Endometrial Cancer Advisory Committee. American Cancer Society Guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J Clin. 2001;51(1):38–75.

    Google Scholar 

  5. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer: a gynecologic oncology group study. Cancer. 1987;60:2035–41.

    Article  CAS  PubMed  Google Scholar 

  6. Zaino R, Whitney C, Brady MF, et al. Simultaneously detected endometrial and ovarian carcinomas: a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol. 2001;83:355–62.

    Article  CAS  PubMed  Google Scholar 

  7. Walsh C, Holschneider C, Hoang Y, et al. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol. 2005;106:693–9.

    Article  PubMed  Google Scholar 

  8. Navarria I, Usel M, Rapiti E, et al. Young patients with endometrial cancer: how many could be eligible for fertility-sparing treatment? Gynecol Oncol. 2009;114:448–51.

    Article  PubMed  Google Scholar 

  9. Arora V, Quinn MA. Endometrial cancer. Best Pract Res Clin Obstet Gynaecol. 2012;26(3):311–24.

    Article  PubMed  Google Scholar 

  10. Lee WL, Lee FK, Su WH, et al. Hormone therapy for younger patients with endometrial cancer. Taiwan J Obstet Gynecol. 2012;51(4):495–505.

    Article  PubMed  Google Scholar 

  11. Mazur MT. Endometrial hyperplasia/adenocarcinoma. A conventional approach. Ann Diagn Pathol. 2005;9:174–81.

    Article  PubMed  Google Scholar 

  12. Dreisler E, Poulsen LG, Antonsen SL et al; European Menopause and Andropause Society. EMAS clinical guide: assessment of the endometrium in peri and postmenopausal women. Maturitas 2013;75(2):181–90.

    Google Scholar 

  13. Leitao Jr MM, Kehoe S, Barakat RR, et al. Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma. Gynecol Oncol. 2009;113:105–8.

    Article  PubMed  Google Scholar 

  14. van Dongen H, de Kroon CD, Jacobi CE, Trimbos JB, Jansen FW. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and metaanalysis. BJOG. 2007;114(6):664–75.

    Article  PubMed  Google Scholar 

  15. Ceci O, Bettocchi S, Pellegrino A, Impedovo L, Di VR, Pansini N. Comparison of hysteroscopic and hysterectomy findings for assessing the diagnostic accuracy of office hysteroscopy. Fertil Steril. 2002;78(3):628–31.

    Article  PubMed  Google Scholar 

  16. Kaneda S, Fujii S, Fukanaga T, et al. Myometrial invasion by endometrial carcinoma: evaluation with 3.0T MR imaging. Abdom Imaging. 2011;36:612–8.

    Article  PubMed  Google Scholar 

  17. Vasconcelos C, Félix A, Cunha TM. Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: comparison of magnetic resonance imaging and histopathologic evaluation. J Obstet Gynaecol. 2007;27:65–70.

    Article  CAS  PubMed  Google Scholar 

  18. Selman TJ, Mann CH, Zamora J, et al. A systematic review of tests for lymph node status in primary endometrial cancer. BMC Womens Health. 2008;8:8.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Horowitz NS, Dehdashti F, Herzog TJ, et al. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol. 2004;95:546–51.

    Article  PubMed  Google Scholar 

  20. Tong XM, Lin XN, Jiang HF, Jiang LY, Zhang SY, Liang FB. Fertility-preserving treatment and pregnancy outcomes in the early stage of endometrial carcinoma. Chin Med J. 2013;126(15):2965–71.

    PubMed  Google Scholar 

  21. Yang S, Thiel KW, Leslie KK. Progesterone: the ultimate endometrial tumor suppressor. Trends Endocrinol Metab. 2011;22:145–52.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Hahn H-S, Yoon S-G, Hong J-S, et al. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer. Int J Gynecol Cancer. 2009;19:1068–73.

    Article  PubMed  Google Scholar 

  23. Corfman PA. Labeling guidance text for progestin-only oral contraceptives. Contraception. 1995;52:71–6.

    Article  Google Scholar 

  24. Montz FJ, Bristow RE, Bovicelli A, Tomacruz R, Kurman RJ. Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol. 2002;186:651–7.

    Article  CAS  PubMed  Google Scholar 

  25. Kudesia R, Singer T, Caputo TA, et al. Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma. Am J Obstet Gynecol. 2014;210:255.e1–4.

    Article  CAS  Google Scholar 

  26. Dhar KK, NeedhiRajan T, Koslowski M, Woolas RP. Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature. Gynecol Oncol. 2005;97:924–7.

    Article  CAS  PubMed  Google Scholar 

  27. Gunderson CC, Fader AN, Carson KA, Bristow RE. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol. 2012;125:477–82.

    Article  CAS  PubMed  Google Scholar 

  28. Minig L, Franchi D, Boveri S, et al. Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women. Ann Oncol. 2011;22:643–49.

    Article  CAS  PubMed  Google Scholar 

  29. Mazzon I, Corrado G, Masciullo V, Morricone D, Ferrandina G, Scambia G. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril. 2010;93:1286–89.

    Article  PubMed  Google Scholar 

  30. Ushijima K, Yahata H, Yoshikawa H, et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol. 2007;25:2798–803.

    Article  CAS  PubMed  Google Scholar 

  31. Gallos ID, Yap J, Rajkhowa M, Luesley DM, Coomarasamy A, Gupta JK. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol. 2012;207(4):266.e1–12.

    Article  Google Scholar 

  32. Chi DS, Barakat RR, Palayekar MJ, et al. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer. 2008;18:269–73.

    Article  CAS  PubMed  Google Scholar 

  33. Richter CE, Qian B, Martel M, et al. Ovarian preservation and staging in reproductive-age endometrial cancer patients. Gynecol Oncol. 2009;114:99–104.

    Article  PubMed  Google Scholar 

  34. Wright JD, Buck AM, Shah M, Burker WM, Schiff PR, Herzog TJ. Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin Oncol. 2009;27:1214–9.

    Article  PubMed  Google Scholar 

  35. Elizur SE, Beiner ME, Korach J, Weiser A, Ben-Baruch G, Dor J. Outcome of in vitro fertilization treatment in infertile women conservatively treated for endometrial adenocarcinoma. Fertil Steril. 2007;88:1562–7.

    Article  PubMed  Google Scholar 

  36. Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol. 2004;95:133–8.

    Article  CAS  PubMed  Google Scholar 

  37. Chiva L, Lapuente F, González-Cortijo L, Carballo N, García JF, Rojo A, et al. Sparing fertility in young patients with endometrial cancer. Gynecol Oncol. 2008;111(2 Suppl):S101–4.

    Article  PubMed  Google Scholar 

  38. Yamagami W, Susumu N, Ichikawa Y, et al. Thirty-four successful cases of pregnancy following fertility-preserving hormonal therapy for endometrial cancer. Gynecol Oncol. 2012;125:S5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics & Gynecology, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India

    Bindiya Gupta MD, MAMS, MICOG & Shalini Rajaram MD, FAMS

Authors
  1. Bindiya Gupta MD, MAMS, MICOG
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shalini Rajaram MD, FAMS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bindiya Gupta MD, MAMS, MICOG .

Editor information

Editors and Affiliations

  1. Obstetrics and Gynecology, University College of Medical Sciences, New Delhi, India

    Shalini Rajaram

  2. Surgical &Gynec Oncology, Lakeshore & Welcare Hospitals, Kochi, Kerala, India

    Chitrathara K

  3. Gynec Onclogy, Tata Memorial Hospital, Mumbai, India

    Amita Maheshwari

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer India

About this chapter

Cite this chapter

Gupta, B., Rajaram, S. (2015). Endometrial Cancers in Young Women: Conservative Management and Fertility Preserving Options. In: Rajaram, S., K, C., Maheshwari, A. (eds) Uterine Cancer. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1892-0_39

Download citation

  • DOI: https://doi.org/10.1007/978-81-322-1892-0_39

  • Publisher Name: Springer, New Delhi

  • Print ISBN: 978-81-322-1891-3

  • Online ISBN: 978-81-322-1892-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation